Gameday reaches out for more sports fans

Published 29-JUN-2016 14:51 P.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Soon-to-be ASX-listed Gameday Mouthguards has announced an additional sales channel for its customisable mouth guards.

Gameday has signed a partnership agreement with Hockey NSW and Hockey Victoria Associations giving it exclusive marketing access to 45,000 hockey members. The agreement effectively raises Gameday’s addressable audience to over 130,000 members across Australia.

Importantly, the agreements increase Gameday’s direct access to sporting association members to over 130,000 members across Australia.

Under exclusive partnership agreements signed with various entities this year, Gameday will collaborate with its partners to promote its custom made but affordable mouth guard product membership bases, via Electronic Direct Marketing, member newsletters, online and social media channels, as well as through an on the ground presence at key hockey events.

As part of the agreement, the Associations are financially incentivised to promote Gameday’s mouthguards to their memberships, with both committing to reinvesting the financial incentives earned from Gameday directly back into their Associations for new equipment and running costs.

Gameday’s Chief Executive Officer Matt Weston added; “Entering these important partnerships with Hockey NSW and Hockey Victoria provides further validation of Gameday’s high quality, low cost mouthguard offering and builds the total sporting membership base that we can offer our product to over 130,000 members across Australia. Through this important channel, we are able to become part of grassroots sporting associations and their communities, helping them to buy new equipment, at the same time as providing affordable safety to players.”

Gameday CEO Matt Weston and Essendon coach John Worsfold



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X